John F. Schindler - Concepedia

Author

John F. Schindler

Pfizer (United States)

Also Known As

J SCHINDLER, J. Schindler, J.F. Schindler, John F Schindler, John F. Schindler

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Iowa Los Alamos National Laboratory University of Akron

About

John F. Schindler is an author at Pfizer (United States) specializing in natural sciences, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	129
2	Natural Sciences	5	5	129
3	Biochemistry	5	5	129
4	Cell Biology	2	2	36
5	Cellular Physiology	1	1	21

John F. Schindler

Publications

949

Citations

H-Index

Page 1

	Year	Citations
Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2) David R. Anderson, Marvin J. Meyers, William F. Vernier, Journal of Medicinal Chemistry	2007	169
Haloalkane Dehalogenases: Structure of a<i>Rhodococcus</i>Enzyme<sup>,</sup> Janet Newman, Thomas S. Peat, R. Richard, Biochemistry	1999	158
A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation Robert J. Mourey, Barry Burnette, Sarah J. Brustkern, Journal of Pharmacology and Experimental Therapeutics	2010	129
A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models Gabriel Mbalaviele, Cynthia D. Sommers, Sheri L. Bonar, Journal of Pharmacology and Experimental Therapeutics	2009	61
Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation Heidi R. Hope, Gary D. Anderson, Barry Burnette, Journal of Pharmacology and Experimental Therapeutics	2009	60
Haloalkane Dehalogenases: Steady-State Kinetics and Halide Inhibition John F. Schindler, Penelope A. Naranjo, David A. Honaberger, Biochemistry	1999	60
Structural Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804 Xing Li, H.-S. Shieh, Shaun R. Selness, Biochemistry	2009	55
Mutagenic investigation of conserved functional amino acids in Escherichia coli L-aspartase. John F. Schindler, Ronald E. Viola Journal of Biological Chemistry Escherichia Coli L-aspartaseBiochemistryCellular EnzymologyNatural SciencesProtein Biosynthesis	1994	44
Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides Eric T. Baima, Julia A. Guzova, Sumathy Mathialagan, Journal of Biological Chemistry	2010	40
Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation Cynthia D. Sommers, Janice Thompson, Julia A. Guzova, Journal of Pharmacology and Experimental Therapeutics	2009	33

Page 1